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Olrctdues, In 193 patients we evaluated The safety and efficacy
44
asapjoplaasty of a critcil stena sis of Ow right coronary artery (52
patients) or the l nntrrlor dekevoW.Nor, oronary artery (141
ptikmts), with the contralaterat corataaary artery occluded and the
dreumfiex artery bewati, without significant stelaut is,
Sacikg Attempted angio y of either the left anterior
descending or the dominant right coronary artery when the
contralateral v b occluded may trigger overwhelming left
ventricular d on or hemody collapse, or both .
MMetlu, te. Immediate lateand outcome (33 do 18 months) in the
Anitly group were compared with outcome in 214 patients who had
ty in both the left anterior descending and right coronary
arteries and in 194 patients who had coronary artery surgery and
were matched for number and location of significant lesions,
e , age, r and study period.
Results. Left ventricular function was normal (38%) or mildly
(34%), moderately (22%) or sever- ,y (6%) compromised. There
Since percutaneous transluminal coronary angioplasty was
introduced by Gruentzig et al . (1), expanded indications
have evolved, and angioplasty is currently offered to an
increasing number of patients as an alternative to coronary
artery bypass surgery . This trend is the result of improved
technology, ancillary devices (perfusion balloons, stents,
directional athereetomy, laser) and operator experience (2) .
Over the past decade, angioplasty has seen increasing use
as a treatment for multivessel coronary artery disease .
However, this expanded indication has evolved in the ab-
sence of results from randomized trials comparing immedi-
ate and long-term outcome of angioplasty versus bypass
surgery in this setting (3,4) .
The anatomic subset of a totally occluded artery with
concomitant severe stenosis of the contralateral vessel
(which is often the source of collateral flow) presents an
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were 11(5.7%) emergency and 5 (2 .6%) elective coronary artery
operations, 3 (1 .6%) myocardial infarctions and I in-hospital
death In the study group. After discharge there were 25 (13 .1 % )
elective coronary operations, 7 (3 .7%) myocardial. infarctions and
9 (4.7%) deaths in the study group. The Incidence of death and
myocardial infarction was similar In all groups, with 80 power
to detect a 7% difference in adverse events . The study group had
more elective surgery before and after discharge than did the
surgical control group (p = 0.02).
Conclusions. Dilating one major vessel when the contralateraal
vessel is occluded appears to be as safe as coronary surgery or
two-vessel angioplasty . Incomplete revascularization in study
group patients did not impair survival or increase myocardial
infarction compared with the angioplasty and surgical control
groups.
fJ Am Coll Cardiol 1993,22 :1298-303)
intriguing revascularization strategy dilemma . It is certainly
possible that bypass surgery may be more efficacious and
safer because surgery can consistently provide complete
revascularization. However, "culprit lesion" angioplasty
has been proposed and actively practiced as a therapeutic
approach for patients with multivessel disease (5) . More
specifically, because of the extent of jeopardized myocar-
dium, the presence of a critical stenosis in either the left
anterior descending or the dominant right coronary artery
while the contralateral artery is totally occluded constitutes
a potentially threatening anatomy for nonsurgical revascu-
larization . The purpose of this study was to evaluate the
safety and efficacy of angioplasty of a stenosis >70% in
either the left anterior descending or the dominant right
coronary artery when the contralateral artery was totally
occluded .
Methods
Study and control groups. Review of the Cleveland Clinic
Foundation Coronary Angioplasty Registry revealed that of
3,607 patients who underwent initial elective angioplasty (no
acute myocardial infarction within <_24 h) from January 1985
to July 1988, 1,649 patients had multivessel disease . The
study group was derived by applying the following criteria :
0735-10971931$6 .00
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1) complete occlusion of the left anterior descending or
dominant right coronary artery . 2) >70% stenosis in the
contralateral vessel, and 3) <50% stenosis of the circumflex
artery .
To address the iss,.,, s of safety and efficacy, matching
angioplasty and surgical control groups were selected . The
angioplasty control group matched the study group with
regard to age, gender, year of procedure and lesion location
and had >70% stenosis in both the left anterior descending
and the right coronary arteries without total occlusion and
<50% stenosiss of the circumflex artery . Angioplasty was
attempted in both vessels . The surgical control group
matched precisely the coronary anatomy, left ventricular
function, age, gender and year of procedure of the study
group. This group was also selected by the criterion of
complete revascularization at surges y .
Clinical, angiographic and procedural data were obtained
from the Coronary Angioplasty Registry and the Cardiovas-
cular Bypass Information Registry at the Cleveland Clinic
and verified by chart and angiographic review .
Definitions . Successful balloon angioplasty was defined
as <50% residual stenosis after angioplasty, with at least a
20% reduction in the original stenosis (angiographic suc-
cess), without in-hospital death . Q wave myocardial infarc-
tion or bypass surgery (clinical success) .
Baseline global left ventricular function was assessed
qualitatively by contrast ventriculography and categorized
as normal, mildly impaired . moderately impaired or severely
impaired . Qualitative assessment was utilized rather than
ejection fraction because 6-in . (15 .2-cm) image intensifiers
were utilized for the majority of left ventriculograms, requir-
ing panning and making ejection fraction determination
imprecise or impossible .
Collateral vessels were defined as poor (faint and incom-
plete opacification of the occluded vessel), or good (com-
plete opacification of the occluded vessel) . Existence, site or
sites of origin and destination of collateral vessels were
specified . Collateral vessels were defined as jeopardized
when the segment of the dilated vessel distal to the lesion
was the major source of the collateral vessels .
Myocardial infarction was defined as the development of
a new significant Q wave in at least two contiguous leads .
Unstable angina was defined as angina of recent onset in the
presence of an accelerating pattern, progressive angina on
effort or angina at rest .
Angiography . Angiographic data were reviewed and tab-
ulated by an angiographer unaware of the clinical outcome .
Stenosis diameter was averaged from caliper measurements
of two orthogonal projections showing the lesion clearly
without overlap or foreshortening .
Follow-up . Follow-up information was obtained from pa-
tient return visits to the hospital, interview by telephone or
mail questionnaire and contact with the referring physicians .
In particular, information was sought with regard to the
occurrence of death, myocardial infarction, repeat revascu-
larization procedures and functional status . The latter was
categorized as representing improvement, worsening or no
change in comparison with the patient's functional capacity
before initial revascularization .
Angioplasty technique. All patients were pretreated with
aspirin and calcium channel blocking agents . A heparin
bolus was given before angioplasty (10,000 to 15,000 IU
intravenously) and as required during the procedure, guided
by activated clotting time titrated >300 s in 1987 to 1988 .
Calcium channel blockers were continued for at least 6
months, nitrates for at least 48 h and aspirin indefinitely .
Coronary surgery procedure . Blood or cold cardioplegia
was used according to operator preference . Bypass surgery
was considered an emergency procedure when it was applied
in patients with suspected or documented ongoing isehemia
or acute closure after angioplasty, or both . Patients without
clinical or elect rocardiographic evidence of ischemia weree
considered as undergoing elective bypass surgery .
Statistical analysis . Relations between outcome of the
angioplasty of the left anterior descending versus the right
coronary artery in the study group and between the study
and control groups were evaluated by the Fisher exact or
chi-square tests for discrete data and the Student i test for
continuous data. Cardiac survival and cardiac survival free
from myocardial infarction and repeat rcvascularization
were estimated by the Kaplan-Meier method . The sample
size included in the study provided >80% power to detect a
~~7% difference in survival between the study and control
groups . Differences between the study and control groups
were tested by log rank tests .
Results
Study and control groups. One hundred ninety-five pa-
tientF satisfied study inclusion criteria . Two patients were
excluded because of incomplete angiographic data, leaving
193 study group patients with 100% occlusion of either the
left anterior descending or the right coronary artery . The
angioplasty control group comprised 214 matched patients
without 100% occlusion, and the surgical control group
comprised 195 matched patients with complete surgical
revascularization . One patient was excluded because of
incomplete angiographic data, leaving 194 evaluable patients
in the surgical control group .
Baseline characteristics . Demographic variables and clin-
ical characteristics of the three patient groups are listed in
Table I . All groups had similar baseline characteristics by
study design . However, a higher incidence of previous
myocardial infarction was noted in the study group (p <
0.05) . I.n addition, the study and surgical control groups had
a higher incidence of moderate or severe left ventricular
dysfunction (28%) compared with the angioplasty control
group (16%) .
The study group comprised 141 patients with an occluded
right coronary artery and 52 patients with an occluded left
anterior descending coronary artery . Both subgroups had
1299
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Table 1 . Clinical Characteristics of the Three Patient Groups
*P < 0 .05 compared with control groups, Values presented are mean value
t SD or percent . CCS - Canadian Cardiovascular Society : LV function
left ventricular function alteration : MI = myocardial infarction .
similar baseline variables and a sini ; : .ir distribution of func-
tional status .
Procedural results and complications . Initial results and
in-hospital events are presented in Table 2 . Results and
in-hospital events by arterial site are presented in Table 3 .
Angiographic success was achieved in 181 patients
(93.8%) and clinical success in 175 patients (90.7%) in the
study group . Eleven of these patients (5.7%) required emer-
gency and five patients (2 .6%) elective prediseharge bypass
surgery. Emergency bypass surgery was more frequent with
angioplasty of the right coronary artery (five patients, 9.6%)
compared with angioplasty of the left anterior descending
coronary artery (6 patients, 4.3%, p = 0.02) . The results in
the study group patients were similar to those in the angio-
plasty and surgical control groups (Table 2) .
No relation was demonstrated between the occurrence of
in-hospital adverse events and jeopardized collateral ves-
sels, There were 63 patients in the study group with collat-
eral vessels that were "jeopardized," arising from a ste-
nosed, contralateral artery . This group had no deaths, two
Table 2. In-Hospital Results and Complications
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Table 3. In-Hospital Events and Procedural Results by Artery
Site in the Study Group
* Value in the surgical control group is significantly different from that in both the study group and the angioplasty
control group
. CABG = coronary artery bypass surgery .
Values presented are mean value ± SD or number (%) . CABG = coronary
artery bypass SL1ftN'1v : LAD n left anterior descending coronary
artery :
RCA ~ right coronary :artery .
emergency bypass operations (3%) and no myocardial infarc-
tions with angioplasty, results that, were not significantly
different from those of patients with nonjeopardized
collat-
eral
vessels,
Angiographic success was obtained in 2114 patients
(95 .3%) and clinical success in 199 (93 .0%) in the angi .,)plasty
control group . Surgical revascularization was complete in all
surgical control group patients. Eight of these patients
(4.1%) required reexploration for bleeding complications .
Follow-up . Mean follow-up was 33 ± 18 months in the
study group, 32 ± 31 months in the surgical control group
and 39 ± 17 months in the angioplasty control group (Table
4). Follow-up completeness was 99%, 97%, and 97% . re-
spectively .
During follow-up, the incidence of cardiac death (2 .1%)
and myocardial infarction (3 .7%) in the study group was
similar to that observed in the angioplasty and surgical
control groups. Actuarial 5-year cardiac survival was similar
for all groups (Fig . 1) . Cardiac death and myocardial infarc-
tion-free survival as well as bypass surgery and repeat
angioplasty-free survival for each group are presented in
Figures 2 and 3 . More patients in both angioplasty groups
had either surgery (study group 13 .1%, control group 8.2%)
or angioplasty (study group 23 .5%, control group 11 .6%)
during follow-up. In addition, study group patients required
more repeat revascularization during follow-up than did
angioplasty control group patients . The symptomatic status
of surviving patients was similar in the three groups (Table
4). At the end of follow-up, 80% of the study patients had
Study Group
(n = 193)
Surgical
Control Group
In = 194)
Angioplasty
Control Group
In = 214) p Vain
Angk)graphic success
181 (93,817r)
204(95 .3%)
NS
Clinical success 175 (90 .1%)
189 (93 .017o) NS
UTentfelective CABG 1 115 (5.7%12 .67r) 0/I (0.017r10.5%)* 7/7 (3
.3c/c/3 .3%) 0.02
Death 1(15%)
30JO 1 M39
NS
Myocardial infarction
1(0.5%) 2(1%)
1 (0 .517c)
NS
LAD (n = 141) RCA (n = 52)
In-hospital events
Urgent/elective CABG 6/4 (4 .3%/2 .8%) 51 (9 .617,11 .9%)
Death 0(0.0%) I (1 .9%)
Myocardial infarction 1 (0.7%) 010.0%x,1
Procedural results
% stenosis before angioplasty 85 ± 11 81 ± 10
Residual 17( stenosis after angioplasty 23 ± 22 21 ± 12
Study Group
in = 193)
Surgical
Control
Group
In = 194)
Angioplasty
Control
Group
in = 214)
Age 59 .5 ± 11 59 .5 ± 13 60 .0 2: 10
Male (%) 75 75
77
Diabetes 20 21 16
Continued smoking (%) 54 49 63
Hypedipemia (%) 30 34 25
Hypertension (%) 44 42 43
M angina class (%)
Class 1=2 44 72 75
10% 3-4 56 28 25
Previous Ml Me) 62* 0 35
LV function (%)
Normal 18 35 48
Mild 34 37 ,16
Moderate 22 21 11
Severe 6 7
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Table 4. Late Outcome
*Surgery control group is significantly different from both the study group and the angioplasty control group
.
experienced sustained functional improvement versus 65Si
in the angioplasty control group and 76% in the surgical
control group .
Complete revascularization . Complete revascularization
was attempted in 40 patients in the study group (with
angioplasty of the occluded right coronary artery (22 pa-
tients] or the left anterior descending coronary artery
118 patients]) and successfully achieved in 30 of them
(75%). Procedural complications included one acute myo-
cardial infarction (2.5%), bypass surgery in one patient
(2.5%) and one death (2.5%) . Follow-up events included
myocardial infarction in two patients (5%), bypass surgery in
six (15%) and one death (2 .5%) . When procedural and
follow-up cardiac events were compared within the study
group between patients with attempted complete revas-
cularization and patients having angioplasty of the nonoc-
cluded vessel only, there were no significant differences .
except for a higher incidence of repeat angioplasty in the
complete revascularization subgroup (57 .7% vs. 21 .2A , ,
p = 0.02) .
Figure 1 . Five-year Kaplan-Meier actuarial cardiac survival for
coronary artery bypass surgery (CABG), angioplasty study
(PTCA-S) and angioplasty control (PTCA-() patient groups .
1301
Discussion
The present study suggests that in the setting of signifi-
cant stenosis of the left anterior descending or dominant
right coronary artery and occlusion of (lie contralateral
artery, angioplasty is as safe as standard multivessel angio-
plasty or bypass surgery . Although a higher incidence of
procedural events could be anticipated because of the pres-
ence of an occluded coronary artery, the procedural event
rate was not different from that in the control groups, and the
rate is consistent with that in published series of angioplasty
in patients with multivessel disease (4,6-8) . Of note, there
was a relatively high incidence of crossover to urgent bypass
surgery in the study group (5 .7%) . This is a reflecticn of both
a conservative approach because the contralateral territory
is subtended by an already occluded artery, as well as the
lack of flow support devices during the time period studied .
The incidence of emergency bypass surgery in the study
group was higher after angioplasty of the right coronary
artery than of the left anterior descending artery (9 .6% vs .
4.3%, p = 0 .02) .
Figure 2 .
Five-year Kaplan-Meier actuarial freedom from cardiac
death and myocardial infarction for coronary artery bypass surgery
(CARG), angioplasty study (PTCA-SI and angioplasty control
(PTCA-Q patient groups .
100
90
-
CABG
	 PTCA-S
PTCA-C
P = 0 .09
0
Number
at Risk
PTCA
Study
CABG
Control
PTCA
Control
Study Group
in = 191)
Surgical Control
Group (n = 188)
Angioplasty Control
Group in = 207)
p Value
Death 9=0 1618 .5`'7
11 153%
NS
Cardiac death 4 (2 .1'6) 7 O .Z%x)
5 (2 .4%) NS
Myocardial infarcliua 7 (3 .7,'6) 7 (Mci) 9 (4 .3 1;'(,)
NS
Bypass surgery 25 (13 .19() 4(2 .11)*
17(8 .29) 0.001
Repeat angioplasty 45 (23A%) 3 (1 .6%)* 24 (11 .6rlo
0 .001
Symptomatic status of
surviving patients
Improved 9ff"( 76r/ 'i 65 % N S
Asymploinatic 76r~
742
80% NS
PTCA-S
PTCA-C
p = 0.77
12 24 36 48 60
Number
et Risk
monme
dyStu
161 109 72 40 16
CABG
174
174 162 131 91
&M01
PTCA
Control
197
163 124 56 26
100
.. ...
97
.7%
97.69%
97
.51
96 .4%
93 .5%
90
-
CABG
_W
12
24 36
Months
48 60
162
107
71 39
16
173
173
161 130 89
194
151 123
55
25
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100
192 .2%96' 7%
p=0 . 0001 1
CABO
PTCA-C
PTA4
59.06
1%
68.1%
Figure 3 . Five-year Kaplan-Meier actuarial freedom from cardiac
death, myocardial infarction and bypass surgery for coronary artery
bypass surgery (CABG), angioplasty study (PrCA-S) and angio-
plasty control (PTCA-0 patient groups .
The present study confirms a previous report (9) that
angioplasty of the left anterior descending coronary artery
when the right coronary artery is occluded appears to be as
safe as angioplasty without occlusion of the right coronary
artery. Similarly, an excellent safety profile has been ob-
served in the setting of left coronary artery (anterior de-
scending or circumflex) angioplasty in the presence of
chronic total occlusion of the right coronary artery (10) .
When collateral flow to a totally occluded vessel is
compromised during balloon inflation, the potential for ad-
verse ischcmic events exists . However, no increased inci-
dence of acute complications was noted in the present series
in the patients who had collateral vessels jeopardized by
balloon inflation. Because acute closure of a vessel providing
collateral flow is an independent predictor of death after
elective angioplasty, careful selection of the lesion to be
dilated and critical assessment of the angioplasty result
cannot be overemphasized 0 D . The relatively high rate of
in-hospital crossover to coronary bypass grafting in the
present study (8 .3%) is a direct reflection of the cautious
approach taken in managing these patients .
In addition to safety, long-term efficacy of a revascular-
ization procedure must justify its widespread clinical accep-
tance. Current revascularization procedures offer palliative
solutions to the management of coronary artery disease . For
an increasing number of patients, both surgery and angio-
plasty may be required over time to effectively control
symptoms and prevent cardiac events, In this context, even
though repeat revascularization procedures are important . it
is the freedom from morbid cardiac events (death and
myocardial infarction) and incapacitating symptoms (func-
tional status) that ultimately characterize efficacy of the
treatment strategy
. Similar rates of cardiac morbid event-
free survival were achieved in the study and surgical control
groups (94.4%% and 94.8%, respectively) (Fig . 1). The angio-
plasty control group experienced a lower, yet not statisti-
JACC Vol
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cally different, cardiac morbid event-free survival (85 .2% .
p = 0 .09) (Fig . 2) . Functional status was similar in all patient
groups, and it was as good for patients with "incomplete"
revascularization in the study group (9,10) .
As expected, owing to restenosis after angioplasty, pa-
tients in the surgical control group enjoyed the highest
freedom from repeat revascularization procedures . The ob-
served difference is maximized by the fact that within a mean
follow-up interval of 33 months, the majority of repeat
revascularization procedures in the angioplasty groups do
occur, whereas repeat revascularization is rather infrequent
in bypass surgery patients in the 1st 7 years (12,13) .
A higher rate of repeat revascularization was observed in
the study group than in the angioplasty control group . The
increased rate of repeat angioplasty procedures in those
study patients with complete revascularization due to the
increased incidence of restenosis in successfully dilated
vessels with chronic total occlusion may, in part, account for
this finding . In addition, a physician-related bias for earlier
crossover to bypass surgery in the presence of restenosis
and total occlusion of the contralateral vessel may also
contribute .
Completeness of revascularization. The controversial is-
sue of complete revascularization in relation to event-free
survival was originally addressed in the context of surgery .
Several studies have confirmed the benefit of complete
revascularization with regard to cardiac event-free survival
and functional status (12,14,15) . Such conclusions are tem-
pered, however, by the relatively short follow-up period in
these series (8) . With longer follow-up duration, Schaff et al .
(16) detected no difference in survival on the basis of
revascularization status .
For angioplasty the issue is even more complex . "Culprit
lesion" angioplasty has been proposed and practiced either
by choice or because of inability to dilate all lesions . Several
studies have suggested a higher cardiac event rate in patients
with incomplete revascularization (6,17-19) . In a recent
study, O'Keefe et al . (20) examined a group of 700 patients
with multivessel disease and an average follow-up duration
of 54 months. A lower cardiac morbid event rate, as well as
more repeat revascularization procedures and a higher re-
currence of anginal symptoms for the subgroup of patients
with incomplete revascularization, were documented . None-
theless, overall long-term survival was similar in both
groups . Reeder et al . (21) concluded that late outcome is not
significantly influenced by the completeness of revascular-
ization, depending more on baseline variables .
The present study suggests that it is both safe and
efficacious to utilize the strategy of incomplete revascular-
ization in patients with multivessel disease Mull chronic
occlusion of one coronary artery and stenosis of the con-
tralateral vessel. Complete revascularization in both angio-
plasty and surgical control groups did not improve the
event-free survival rate . The 40 study patients having com-
plete revascularization had a higher rate of repeat angio-
plasty than did study patients with incomplete revascular-
PycA "*
115 66 44 22 10
C"(h4 173 173 156
120
67
VA 000 - 173 142 too 40 23
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ization (57.7% vs . 26.2%, p = 0 .02), an observation that is
consistent with the initial National Heart, Lung . and Blood
Institute's Angioplasty Registry data (21) .
Study limitations . This study was retrospective, and
therefore conclusions need to he carefully considered . A
longer follow-up period would have been desirable to pro-
vide a more precise assessment of the relative role of the
revascularization strategies used . However, despite these
limitations, useful guidelines can be offered in the manage-
ment of this subset of patients with two-vessel coronary
artery disease .
Clinical implications. Angioplasty of the contralateral at--
tery when either the left anterior descending or the right
coronary artery is occluded appears to be as safe as bypass
surgery or standard multivessel angioplasty with less than
total occlusion . Although angioplasty provided incomplete
revascularizat ion for most patients in the study group
091%h this did not have a negative impact on cardiac
morbid event-free survival compared with that in the surgi-
cal and angioplasty control groups. Therefore, angioplasty
offers a viable alternative to bypass surgery in carefully
selected patients with two-vessel (left anterior descending
and dominant right coronary artery) disease with total oc-
clusion of one vessel, with the understanding that -20% of
patients will cross over to bypass surgery over the next 4
years . Valuable information on the impact of incomplete
revascularization on event-free survival is expected to be-
come available from data analysis of multivessel coronary
artery disease trials randomizing patients to angioplasty
versus bypass surgery (Bypass Angioplasty Revasculari7a-
tion Investigation [BART], Coronary Angioplasty By Eras,
Revascularization Investigation [CABRI], Emory Angio-
plasty Surgery Trial [EAST], German Angioplasty-Bypass
Intervention 16ABIJ trial, Randomized Interventional Treat-
ment of Angina [RITA]) in the future .
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